Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-92.29	14.57	-188.89
Graham Fair Price	38.75	1948.97	1404.65
PEG	-88.84	0.17	-1.56
Price/Book	-5.84	0.97	1.03
Price/Cash Flow	inf	0.00	115.43
Prices/Earnings	-27.84	10.02	13.89
Price/Sales	27.61	1.93	1.51
Price/FCF	inf	0.00	115.43
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	803660.88	0.14	< 0.005
ROA	53.66	< 0.005	< 0.005
ROE	0.02	0.02	30.47
ROIC	< 0.005	0.05	638600.95
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	< 0.005	-300.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.00	7093.79	706981.25
EPS QOQ	-0.09	0.58	546.53
FCF QOQ	0.39	-1.00	158.59
Revenue QOQ	0.58	-0.12	-79.82
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.10	0.08	-15.02
Quick Ratio	17.79	19.88	11.79
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	2174.58	2641.48	21.47
Cash	4599.60	4628.10	0.62
Capex	0.00	0.00	0.00
Free Cash Flow	19.41	0.00	inf
Revenue	1484.96	1330.92	-10.37
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	18.28	20.52	12.26
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-420.36	39.25	-90.66
Naive Interpretation	Member

06 - Financial Health · Bad

Rating